Cervical Cancer Chemoprevention Using Hippobroma longiflora Extract through Modulation of Ki-67 and p53 in Benzo[a]pyrene-Induced Wistar Rats

Ana Bina Sari, Eman Sutrisna, Daniel Joko Wahyono

Abstract


Background: Cervical cancer remains one of the most common malignancies affecting women worldwide and is closely linked to dysregulated cell proliferation and impaired tumor suppressor responses. Herbs contain effective anticancer compounds that may be used alone or as adjuvants to existing chemotherapy regimens to improve efficacy and/or reduce drug-induced toxicity. Hippobroma longiflora (L.) G.Don a or kitolod is a medicinal plant known to contain antioxidant and anticancer compounds. This study evaluated the effect of ethanol extract of kitolod leaves on Ki-67 and p53 expression in a Benzo[a]pyrene (B[a]P)-induced cervical carcinogenesis model in female Wistar rats.

Methods: This experimental study used a post-test-only control group design. Female Wistar rats (n=25) were grouped into five groups: a healthy control group without B[a]P exposure, a negative control group receiving only B[a]P (0.3 mg/kg BW/day); and three treatment groups receiving B[a]P combined with kitolod leaf extract at doses of 100, 200, or 300 mg/kg BW/day for 30 days. Phytochemical screening and gas chromatography–mass spectrometry (GC-MS) were used to characterize the extract. Cervical histopathologal and immunohistochemical examinations were performed to assess Ki-67 and p53 expression. Data were analyzed using one-way ANOVA followed by Bonferroni post hoc tests, with p<0.05 considered statistically significant.

Results: Compared with the negative control, kitolod leaf extract significantly reduced Ki-67 expression and increased p53 expression (p<0.001). The greatest effect was observed at the 300 mg/kg BW/day dose.

Conclusions: Kitolod leaf ethanol extract modulates Ki-67 and p53 expression in B[a]P-exposed rats, suggesting anti-proliferative activity and enhancement of tumor suppressor responses during early cervical carcinogenesis.


Keywords


Benzo[a]pyrene, cervical carcinogenesis, Hippobroma longiflora (L.) G.Don, Ki-67, p53

Full Text:

PDF

References


  1. ulistyawati D, Faizah Z, Kurniawati EM. An association study of cervical cancer correlated with the age of coitarche in Dr. Soetomo Hospital Surabaya. Indonesian Journal of Cancer. 2020;14(1):3–7. doi:10.33371/ijoc.v14i1.639
  2. Ambari E, Winarto H, Sutrisna B, Siregar B. Caspase-3 can not be used to predict the response to neoadjuvant chemotherapy regiment PVB in cervical cancer stage IB-IIA. Indones J Obstet Gynecol. 2013;1(3):156–160. doi:10.32771/inajog.v1i3.357
  3. Wang CZ, Calway T, Yuan CS. Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med. 2012;40(4):657–69. doi:10.1142/S0192415X12500498
  4. Seca AML, Pinto DCGA. Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci. 2018;19(1):263. doi:10.3390/ijms19010263
  5. Li C, Wang Y, Gao S, Hu M, You M. The chemoprevention effects of two herbal mixtures on chemically induced lung tumorigenesis in mice. Pharmaceuticals (Basel). 2023;16(12):1666. doi:10.3390/ph16121666
  6. Ibrahim A, Bulan AS, Ramadhan MR, Bone M, Rija’i HR, Rusman A, et al. Secondary metabolites and cytotoxicity of Kitolod leaf extract (Hippobroma longiflora (L.) G. Don to shrimp larvae (Artemia salina Leach). J Riseta Naturafarm. 2025;2(1):33–42. doi:10.70392/jrn.v2i1.3342.
  7. Dewantoro AI, Putri SH, Mardawati E. Analisis kualitatif kandungan senyawa polifenol pada daun herba kitolod (Hippobroma longiflora (L.) G.don) dan potensi pemanfaatannya sebagai sumber polifenol alami. Agrointek. 2022;16(3):412–9. doi:10.21107/agrointek.v16i3.13235
  8. Imelda E, Fitria U, Mutia UP, Syahrul S, Sari MD, Adev SM, et al. Hippobroma longiflora l leaves as a natural inhibitor of cataract progression: a comprehensive study integrating ethanol extract, HPLC, and molecular docking approaches. Grimsa J Sci Eng Technol. 2023;1(2):40–51. doi:10.61975/gjset.v1i2.10
  9. Wei Y, Zhao L, He W, Yang J, Geng C, Chen Y, et al. Benzo[a]pyrene promotes gastric cancer cell proliferation and metastasis likely through the aryl hydrocarbon receptor and ERK-dependent induction of MMP9 and c-myc. Int J Oncol. 2016;49(5):2055–63. doi:10.3892/ijo.2016.3674
  10. Qasim YA, Saeed SZ, Rashid IM. Immunohistochemical study of P53 and Ki-67 expression in surface epithelial tumor of the ovary. Saudi J Pathol Microbiol. 2017;2(3):52–9. doi:10.21276/sjpm.2017.2.3.3
  11. Mahayasa IMW, Tobing MDL, Harsono AB. Hubungan antara ekspresi Ki-67 dan kaspase-3 dengan respons kemoterapi neoajuvan pada pasien karsinoma serviks stadium IB2 dan IIA2 di Rumah Sakit Dr. Hasan Sadikin, Bandung. Indonesian J Cancer. 2016;10(2):49–54. doi: 10.14414/ijoc.v10i2.425
  12. Odujoko O, Omoniyi-Esan G, Komolafe A, Adegoke A, Olasode B. p53 and Ki67 expression by cervical cancers in Ile-Ife, Nigeria. Br J Med Med Res. 2016;17(9):1–9. doi:10.9734/BJMMR/2016/21697
  13. Nugrohowati N, Setyowati ME, Kusuma T. Association between p53 status and breast cancer molecular subtypes in the Academic Hospital of Universitas Gadjah Mada. eJKI. 2025;13(1):59–66. doi:10.23886/ejki.13.964.59
  14. Siddiqui SS, Rahman S, Rupasinghe HPV, Vazhappilly CG. Dietary flavonoids in p53—mediated immune dysfunctions linking to cancer prevention. Biomedicines. 2020;8(8):286. doi:10.3390/biomedicines8080286
  15. Martiningsih NW, Mudianta IW, Suryanti IAP. Phytochemical screening and antioxidant activity of hippobroma longiflora extracts. IOP Conf Ser: Mater Sci Eng. 2021;1115(1):012078. doi:10.1088/1757-899X/1115/1/012078
  16. Sundov D, Caric A, Mrklic I, Gugic D, Capkun V, Hofman ID, et al. P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas. Diagn Pathol. 2013;8:21. doi:10.1186/1746-1596-8-21
  17. Kim SW, Roh J, Park CS. Immunohistochemistry for pathologists: protocols, pitfalls, and tips. J Pathol Transl Med. 2016;50(6):411–8. doi:10.4132/jptm.2016.08.08
  18. Ahmad Fauzi MF, Wan Ahmad WSHM, Jamaluddin MF, Lee JTH, Khor SY, Looi LM, et al. Allred scoring of ER-IHC stained whole-slide images for hormone receptor status in breast carcinoma. Diagnostics (Basel). 2022;12(12):3093. doi:10.3390/diagnostics12123093
  19. Wanandi SI, Maghdalena M. The potency of herbal active compounds as immune modulators for cancer therapy. Indonesian J Cancer. 2023;17(2):152. doi:10.33371/ijoc.v17i2.956
  20. De Vincentiis M, Censi F, Leopizzi M, Natalizi S, Sardella B, Gallo A, et al. Immunohistochemical expression of fatty acid synthase, Ki-67, and p53 in squamous cell carcinomas of the larynx. Int J Biol Markers. 2008;23(3):176–181. doi:10.1177/172460080802300307
  21. Mohapatra I, Harshini N, Samantaray SR, Sahitya KA. Immunohistochemical expression of P53 and Ki-67 on epithelial tumors of ovary. Int J Reprod Contracept Obstet Gynecol. 2021;10(3):1005–10. doi:10.18203/2320-1770.ijrcog20210724.
  22. Ozaki T, Nakagawara A. Role of p53 in cell death and human cancers. Cancers (Basel). 2011;3(1):994–1013. doi:10.3390/cancers3010994
  23. Honeywell ME, Isidor MS, Harper NW, Fontana RE, Cruz-Gordillo P, Porto SA, et al. p53 controls choice between apoptotic and non-apoptotic death following DNA damage. bioRxiv [Preprint]. 2023:2023.01.17.524444. doi: 10.1101/2023.01.17.524444.
  24. Köbel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, et al. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res.. 2016;2(4):247–58. doi:10.1002/cjp2.53




DOI: https://doi.org/10.15850/amj.v13n2.4633

Article Metrics

Abstract view : 12 times
PDF - 5 times


 This Journal indexed by

                  

           

 

Creative Commons License
AMJ is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats